Subtopic Deep Dive

Hop Phytoestrogens Estrogenic Activity
Research Guide

What is Hop Phytoestrogens Estrogenic Activity?

Hop phytoestrogens' estrogenic activity refers to the estrogen receptor binding and modulation by prenylated flavonoids like 8-prenylnaringenin (8-PN) from Humulus lupulus, investigated for menopausal symptom relief and endocrine effects.

8-PN is the most potent phytoestrogen identified in hops, surpassing other plant estrogens in receptor affinity (Štulíková et al., 2018, 97 citations). Studies compare hop extracts to licorice for menopausal applications, highlighting 8-PN's selective estrogen receptor modulation (Hajirahimkhan et al., 2013, 92 citations). Research spans over 50 papers on binding assays, in vivo models, and clinical implications.

Curated Papers

Key Challenges

Why It Matters

Hop phytoestrogens offer alternatives to hormone replacement therapy for hot flashes and night sweats, reducing cancer risks associated with synthetics (Hajirahimkhan et al., 2013, Planta Medica, 80 citations). 8-PN modulates estrogen synthesis and metabolism, impacting women's health in menopause and hormone-dependent conditions (van Duursen, 2017, 75 citations). Clinical trials show hop extracts improve sleep in women via estrogenic and sedative effects (Franco et al., 2012, 56 citations), informing botanical supplements and beer-derived nutraceuticals.

Key Research Challenges

Long-term Safety Assessment

Chronic 8-PN exposure risks disrupting hypothalamo-pituitary-uterine axis in rats after 3 months (Christoffel et al., 2006, 51 citations). Human trials lack data on endocrine disruption at supplement doses. Balancing efficacy against proliferation risks in estrogen-sensitive tissues remains unresolved (Štulíková et al., 2018).

Potency Quantification Variability

Estrogenic activity assays vary between in vitro binding and in vivo metabolism, complicating comparisons with licorice species (Hajirahimkhan et al., 2013, PLoS ONE, 92 citations). Prenylflavonoid bioavailability differs across hop extracts (Keiler et al., 2013, 67 citations). Standardization of 8-PN levels in commercial products is inconsistent.

Selective Receptor Modulation

Achieving tissue-specific estrogen receptor activation without uterine proliferation challenges therapeutic use (Keiler et al., 2013). Non-estrogenic hop derivatives like xanthohumol show metabolic benefits but weaker estrogenic profiles (Miranda et al., 2018, 68 citations). Mechanisms distinguishing ERα from ERβ effects need clarification.

Essential Papers

Therapeutic Perspectives of 8-Prenylnaringenin, a Potent Phytoestrogen from Hops

Kateřina Štulíková, Marcel Karabín, Jakub Nešpor et al. · 2018 · Molecules · 97 citations

Hop (Humulus lupulus L.), as a key ingredient for beer brewing, is also a source of many biologically active molecules. A notable compound, 8-prenylnaringenin (8-PN), structurally belonging to the ...

Evaluation of Estrogenic Activity of Licorice Species in Comparison with Hops Used in Botanicals for Menopausal Symptoms

Atieh Hajirahimkhan, Charlotte Simmler, Yuan Yang et al. · 2013 · PLoS ONE · 92 citations

The increased cancer risk associated with hormone therapies has encouraged many women to seek non-hormonal alternatives including botanical supplements such as hops (Humulus lupulus) and licorice (...

Botanical Modulation of Menopausal Symptoms: Mechanisms of Action?

Atieh Hajirahimkhan, Birgit M. Dietz, Judy L. Bolton · 2013 · Planta Medica · 80 citations

Menopausal women suffer from a variety of symptoms, including hot flashes and night sweats, which can affect quality of life. Although it has been the treatment of choice for relieving these sympto...

Modulation of estrogen synthesis and metabolism by phytoestrogens<i>in vitro</i>and the implications for women's health

Majorie B.M. van Duursen · 2017 · Toxicology Research · 75 citations

Abstract Phytoestrogens are increasingly used as dietary supplements due to their suggested health promoting properties, but also by women for breast enhancement and relief of menopausal symptoms. ...

Non-estrogenic Xanthohumol Derivatives Mitigate Insulin Resistance and Cognitive Impairment in High-Fat Diet-induced Obese Mice

Cristobal L. Miranda, Lance A. Johnson, Oriane de Montgolfier et al. · 2018 · Scientific Reports · 68 citations

Hop Extracts and Hop Substances in Treatment of Menopausal Complaints

Annekathrin M. Keiler, Oliver Zierau, Georg Kretzschmar · 2013 · Planta Medica · 67 citations

Hop extract is a long used medicinal product and, regarding hormonal activities, in 1999 a number of prenylflavanones have been identified as its major constituents with 8-prenylnaringenin (8-PN) b...

An Updated Review of the Genus Humulus: A Valuable Source of Bioactive Compounds for Health and Disease Prevention

Katya Carbone, F. Gervasi · 2022 · Plants · 62 citations

The medicinal potential of hop (Humulus lupulus L.) is widely cited in ancient literature and is also allowed in several official pharmacopoeias for the treatment of a variety of ailments, mainly r...

Reading Guide

Foundational Papers

Start with Hajirahimkhan et al. (2013, PLoS ONE, 92 citations) for comparative estrogenic assays of hops vs licorice; Keiler et al. (2013, 67 citations) for prenylflavanone identification and menopausal use; Christoffel et al. (2006, 51 citations) for chronic exposure risks.

Recent Advances

Štulíková et al. (2018, 97 citations) for therapeutic perspectives; Carbone and Gervasi (2022, 62 citations) for bioactive compound updates; Miranda et al. (2018, 68 citations) for non-estrogenic derivative insights.

Core Methods

Yeast two-hybrid estrogen screens, E-Screen with MCF-7 cells, alkaline phosphatase assays in rat uterus, HPLC-MS for prenylnaringenin quantification, and qPCR for receptor expression.

How PapersFlow Helps You Research Hop Phytoestrogens Estrogenic Activity

Discover & Search

Research Agent uses searchPapers('8-prenylnaringenin estrogenic activity hops') to retrieve 50+ papers including Štulíková et al. (2018, 97 citations), then citationGraph to map influences from Hajirahimkhan et al. (2013). exaSearch uncovers hop-menopause reviews; findSimilarPapers expands to prenylflavonoid analogs.

Analyze & Verify

Analysis Agent applies readPaperContent on Štulíková et al. (2018) to extract binding affinity data, verifyResponse with CoVe against van Duursen (2017) for metabolism claims, and runPythonAnalysis to plot dose-response curves from extracted IC50 values using NumPy/pandas. GRADE grading scores evidence as moderate for menopausal efficacy due to preclinical dominance.

Synthesize & Write

Synthesis Agent detects gaps in long-term human trials via contradiction flagging between Christoffel et al. (2006) rat data and clinical gaps, generates exportMermaid diagrams of ER signaling pathways. Writing Agent uses latexEditText for manuscript sections, latexSyncCitations with 10 hop papers, and latexCompile for PDF review.

Use Cases

"Extract and plot 8-PN estrogen receptor binding affinities from hop phytoestrogen papers"

Research Agent → searchPapers → Analysis Agent → readPaperContent(Štulíková 2018) → runPythonAnalysis (pandas plot IC50 vs competitors) → matplotlib figure of potency comparison.

"Draft LaTeX review on hop vs licorice for menopause with citations"

Research Agent → citationGraph(Hajirahimkhan 2013) → Synthesis Agent → gap detection → Writing Agent → latexEditText(intro) → latexSyncCitations(5 papers) → latexCompile → formatted PDF section.

"Find GitHub repos analyzing hop estrogenic assay code from papers"

Research Agent → paperExtractUrls(Keiler 2013) → Code Discovery → paperFindGithubRepo → githubRepoInspect → verified Python scripts for ER binding simulations.

Automated Workflows

Deep Research workflow scans 50+ papers on 'hop 8-PN menopausal efficacy' → structures report with GRADE-scored sections on efficacy/safety. DeepScan applies 7-step verification: search → read → CoVe → Python stats on citation networks → gap report. Theorizer generates hypotheses on 8-PN ERβ selectivity from Miranda et al. (2018) and van Duursen (2017).

Try Doxa for Hop Phytoestrogens Estrogenic Activity Research

Frequently Asked Questions

What defines hop phytoestrogens' estrogenic activity?

Estrogenic activity stems from 8-prenylnaringenin's high-affinity binding to estrogen receptors α and β, exceeding genistein and coumestrol (Štulíková et al., 2018).

What methods assess this activity?

In vitro yeast estrogen screen, MCF-7 proliferation assays, and rat uterine models quantify potency; HPLC-MS standardizes 8-PN levels (Hajirahimkhan et al., 2013, PLoS ONE).

What are key papers?

Štulíková et al. (2018, 97 citations) reviews 8-PN therapeutics; Hajirahimkhan et al. (2013, 92 citations) compares hops to licorice; Keiler et al. (2013, 67 citations) details menopausal extracts.

What open problems exist?

Long-term human safety beyond 3 months, optimal dosing without proliferation, and ER subtype selectivity for non-uterotrophic effects remain unresolved (Christoffel et al., 2006).